Quick Answer
Electromedical Technologies, Inc reported Diluted EPS of $0.00 per share for fiscal year 2023.
Electromedical Technologies, Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | $0.00 | +100.0% |
| 2022 | -$0.03 | +87.5% |
| 2021 | -$0.24 | -20.0% |
| 2020 | -$0.20 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $0.00 | — | +100.0% |
| March 31, 2024 | -$0.00 | +0.0% | — |
| September 30, 2023 | $0.00 | +100.0% | — |
| June 30, 2023 | $0.00 | — | +100.0% |
| March 31, 2023 | -$0.00 | +80.0% | +80.0% |
| September 30, 2022 | -$0.01 | +83.3% | — |
| June 30, 2022 | $0.00 | +100.0% | +100.0% |
| March 31, 2022 | -$0.01 | +90.9% | +83.3% |
- Electromedical Technologies, Inc showed an increase of +100.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2023 period, Electromedical Technologies, Inc’s diluted eps has grown by 100.0% (from $0.20 per share (loss) to $0.00 per share).
- The most recent figure is from Electromedical Technologies, Inc’s fiscal year 2023 report (Form 10-K), filed with the SEC on May 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: